Asian Phytoceuticals PCL (BKK:APCO-R) ROE %: 12.41% (As of Mar. 2026) — Near Median


BKK:APCO-R Asian Phytoceuticals PCL BKK:APCO-R
62 GF Score
Price ฿6.27
GF Value ฿7.46
! 4 Warning Signs
View Full Analysis

What is Asian Phytoceuticals PCL ROE %?

Asian Phytoceuticals PCL BKK:APCO-R 62 ROE % is 12.41% as of Mar. 2026, which is 2% below its 10-year median of 12.68. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.46. The stock has 4 warning signs investors should review. Among 1,915 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 65.95% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Asian Phytoceuticals PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿70.2 Mil. Asian Phytoceuticals PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ฿566.1 Mil. Therefore, Asian Phytoceuticals PCL's annualized ROE % for the quarter that ended in Mar. 2026 was 12.41%.

The historical rank and industry rank for Asian Phytoceuticals PCL's ROE % or its related term are showing as below:

BKK:APCO-R' s ROE % Range Over the Past 10 Years
Min: 9.38   Med: 12.68   Max: 21.59
Current: 10.95

During the past 13 years, Asian Phytoceuticals PCL's highest ROE % was 21.59%. The lowest was 9.38%. And the median was 12.68%.

BKK:APCO-R's ROE % is ranked better than
65.95% of 1915 companies
in the Consumer Packaged Goods industry
Industry Median: 6.75 vs BKK:APCO-R: 10.95

Asian Phytoceuticals PCL  (BKK:APCO-R) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=70.236/566.1055
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(70.236 / 198.188)*(198.188 / 638.2275)*(638.2275 / 566.1055)
=Net Margin %*Asset Turnover*Equity Multiplier
=35.44 %*0.3105*1.1274
=ROA %*Equity Multiplier
=11 %*1.1274
=12.41 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=70.236/566.1055
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (70.236 / 88.42) * (88.42 / 57.616) * (57.616 / 198.188) * (198.188 / 638.2275) * (638.2275 / 566.1055)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7943 * 1.5346 * 29.07 % * 0.3105 * 1.1274
=12.41 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Asian Phytoceuticals PCL ROE % Related Terms


Asian Phytoceuticals PCL ROE % Historical Data

* Premium members only.

The historical data trend for Asian Phytoceuticals PCL's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asian Phytoceuticals PCL ROE % Chart

Asian Phytoceuticals PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.54 13.45 17.66 9.38 9.95

Asian Phytoceuticals PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.92 9.73 11.13 10.86 12.41

BKK:APCO-R vs PG, CL, KVUE: ROE % Comparison

For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asian Phytoceuticals PCL ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's ROE % distribution charts can be found below:

* The bar in red indicates where Asian Phytoceuticals PCL's ROE % falls into.


BKK:APCO-R
62GF Score
Asian Phytoceuticals PCL BKK:APCO-R
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asian Phytoceuticals PCL ROE % Calculation

Asian Phytoceuticals PCL's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=55.413/( (556.823+556.962)/ 2 )
=55.413/556.8925
=9.95 %

Asian Phytoceuticals PCL's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=70.236/( (556.962+575.249)/ 2 )
=70.236/566.1055
=12.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 12.41% mean?
Asian Phytoceuticals PCL (BKK:APCO-R) has a ROE % of 12.41% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Asian Phytoceuticals PCL and its competitors. This is near median its historical median of 12.68. Over the past decade, Asian Phytoceuticals PCL's ROE % has ranged from 9.38 to 21.59. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #652 out of 1915 companies in the Consumer Packaged Goods industry, placing it in the top 34%.
Is Asian Phytoceuticals PCL's ROE % too high?
Asian Phytoceuticals PCL's current ROE % of 12.41% is near median its 10-year median of 12.68. Over the past 10 years, this metric has ranged from a low of 9.38 to a high of 21.59. The Consumer Packaged Goods industry median ROE % is 6.75. Asian Phytoceuticals PCL's value of 12.41% is 83.9% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #652 out of 1915 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's ROE % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #652 out of 1915 companies for ROE %. This puts Asian Phytoceuticals PCL in the upper half of its industry. The industry median ROE % is 6.75. Asian Phytoceuticals PCL's value of 12.41% is 83.9% above this benchmark. Historically, Asian Phytoceuticals PCL's own ROE % has ranged from 9.38 to 21.59 over the past decade. While the company's 10-year median is 12.68 vs. the industry median of 6.75, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.75, based on 1,915 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current ROE % of 12.41% is 83.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current ROE % is 12.41%, which is near median its own 10-year median of 12.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current ROE % of 12.41%. The stock's GF Value™ is ฿7.46, compared to a current price of ฿6.27 — trading 15.9% below its estimated fair value. The current ROE % is 12.41%, which is near median its 10-year median of 12.68 and 83.9% above the Consumer Packaged Goods industry median of 6.75. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current ROE % is 12.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?

Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued. The current stock price of ฿6.27 is trading 15.9% below its estimated GF Value™ of ฿7.46.

Key valuation signals for BKK:APCO-R:

  • ROE %: 12.41% (near median its 10-year median of 12.68)
  • GF Value™: ฿7.46 vs. price of ฿6.27 (15.9% below fair value)
  • GF Score™: 62/100 with 4 warning signs
  • Industry Position: 83.9% above the Consumer Packaged Goods median (#652 of 1915)

No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Asian Phytoceuticals PCL Business Description

Other Exchanges APCO:Thailand
Address 84/3 Moo 4 Highway No.11 Road, Northern Region Industrial Estate West, Banklang, Muang Lamphun, Lumphun, THA, 51000
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score

Get the complete analysis for BKK:APCO-R

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿6.27
Price
฿7.46
GF Value